VFA
NPTN

Virtus Fund Advisers’s NEOPHOTONICS CORP NPTN Stock Holding History

Virtus Fund Advisers’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-18,587
Closed -$201K – 558
2016
Q4 		$201K Buy
18,587
+3,980
+27% +$53.1K ﹤0.01% 396
2016
Q3 		$239K Buy
+14,607
New +$206K ﹤0.01% 393

Other funds holding NPTN

OMC
Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtus Fund Advisers's NPTN Position: Q1 2017 in Review

Virtus Fund Advisers sold out of NEOPHOTONICS CORP (NPTN) in Q1 2017, closing a stake of 18,587 shares — an estimated $201K sold.

Virtus Fund Advisers first reported a position in NPTN in Q3 2016 and held it in 2 quarters. The position peaked at $239K in Q3 2016. 126 funds tracked by Wall St. Rank hold NPTN as of Q1 2017.

  • Virtus Fund Advisers reported no remaining NEOPHOTONICS CORP position as of Q1 2017 after selling out during the quarter.
  • Virtus Fund Advisers sold 18,587 NEOPHOTONICS CORP shares in Q1 2017, an estimated $201K.
  • Virtus Fund Advisers first reported a position in NEOPHOTONICS CORP in Q3 2016 and held it in 2 quarters.
  • Virtus Fund Advisers's NEOPHOTONICS CORP position peaked at $239K in Q3 2016.
  • 126 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2017.

Based on Virtus Fund Advisers's 13F filing for Q1 2017, filed 9 May 2017.